Eliquis approved in Europe for treatment of DVT, PE

  • July 29, 2014

Bristol-Myers Squibb and Pfizer announced that apixaban, a novel oral anticoagulant, has been approved by the European Commission for the treatment of deep vein thrombosis and pulmonary embolism and the prevention of recurrent DVT and PE in adults.

The approval covers all countries in the European Union, as well as Iceland and Norway, according to a press release from the companies.

Full Story »

More »
More »
  • Blog
  • Dmitry Feldman MD
  • Eye on Intervention
  • Dmitriy N. Feldman, MD, discusses whether appropriate use criteria should guide reimbursement policies.
More »
More »
More »
More »

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!